Héctor Ortega

Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

Héctor Ortega, Mark C. Liu, Ian Pavord et al. · New England Journal of Medicine · 2014 · 2.3K citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +16

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

Ian Pavord, Stephanie Korn, Peter Howarth et al. · The Lancet · 2012 · 2.2K citations

Life Sciences, Internal Medicine, Pharmacotherapy +14

Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma

Elisabeth H. Bel, Sally E. Wenzel, Philip J. Thompson et al. · New England Journal of Medicine · 2014 · 1.6K citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies

Héctor Ortega, Steven W. Yancey, Bhabita Mayer et al. · The Lancet Respiratory Medicine · 2016 · 552 citations

Life Sciences, Immunology, Pharmacotherapy +16

An Antibody Against IL-5 Reduces Numbers of Esophageal Intraepithelial Eosinophils in Children With Eosinophilic Esophagitis

Amal Assa’ad, Sandeep K. Gupta, Margaret H. Collins et al. · Gastroenterology · 2011 · 431 citations · Full text

Life Sciences, Immunology, Pediatrics +16